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Tunicamycin acts on cell aggregation in Dictyostelium dis-
coideum by changing cell movement and by inhibiting the
EDTA-stable type of intercellular adhesion. Tunicamycin-
treated cells show unco-ordinated pseudopodial activity such
that pseudopods are simultaneously extended from all parts
of the cell surface, and the cells are unable to move in straight
paths. Concurrent with the inhibition of formation of
EDTA-stable contacts, N-glycosylation of a glycoprotein
specific for aggregation-competent cells is inhibited. This gly-
coprotein, previously called contact site A, has an apparent
mol. wt. of 80 kilodaltons (kd). In membranes of tunicamy-
cin-treated cells, two components are detected that react with
certain monoclonal antibodies against contact sites A: one
component of 66 kd, the other of 53 kd apparent mol. wt.
Another group of monoclonal antibodies reacts only with the
80-kd glycoprotein and the 66-kd component. These results
are in accord with the assumption that the glycoprotein car-
ries two carbohydrate chains, and that the antibodies differ in
their requirement for glycosylation of the antigen. Despite the
coincidence between blockage of EDTA-stable cell adhesion
and inhibited glycosylation of contact sites A, direct involve-
ment of the carbohydrate moieties of this glycoprotein in in-
tercellular adhesion seems questionable. EDTA-stable cell
adhesion has not been blocked by Fab fragments from anti-
bodies that specifically react with the glycosylated protein.
Key words: glycoprotein/tunicamycin/cell adhesion/mono-
clonal antibodies/Dictyostelium
Introduction
Aggregating cells of Dictyostelium discoideum adhere to
each other. They form stream-like aggregates and, under the
influence of the chemo-attractant cyclic AMP, they move to-
wards aggregation centers. There, the cells assemble into a
multicellular mass, which eventually develops into a fruiting
body (for reviews on aggregation, see van Haastert and
Konijn, 1982; Gerisch, 1982).
Aggregating cells are distinguishable from those at earlier
stages of development by the resistance of their intercellular
adhesion to EDTA (Gerisch, 1961). Attempts to identify the
cell surface molecules involved in the adhesion of aggregating
cells have led to the identification of a glycosylated (Muller et
al., 1979) and phosphorylated (Coffman et al., 1981; Schmidt
and Loomis, 1982) integral membrane protein (Stadler et al.,
1982), called contact site A (Beug et al., 1973b). This glyco-
protein has been shown to neutralize univalent antibody frag-
ments (Fab) that block the EDTA-stable type of cell adhesion
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(Muller and Gerisch, 1978). It has an apparent mol. wt. of
- 800 kd is absent from growth phase cells, and is expressed
on the cell surface simultaneously with the acquisition of
EDTA-stable contact formation (Beug et al., 1973b; Murray
et al., 1981; Ochiai et al., 1982).
Tunicamycin blocks N-glycosylation of proteins by in-
hibiting the transfer of N-acetylglucosamine-l-phosphate
from UDP-N-acetyl-glucosamine to polyprenolphosphate
(Takatsuki et al., 1975; Tkacz and Lampen, 1975; Lehle and
Tanner, 1976). Earlier findings that tunicamycin inhibits cell
aggregation of D. discoideum (Ochiai et al., 1981) have
prompted us to study the inhibition of EDTA-stable cell con-
tact formation in relation to inhibition of contact site A
glycosylation. Monoclonal antibodies reacting with different
portions of the glycoprotein have been used to identify two
incomplete forms or fragments of the glycoprotein.
Results
Inhibition of EDTA-stable cell adhesion by tunicamycin
Tunicamycin inhibited cell aggregation in D. discoideum
without inhibiting cell motility. Cells were shaken in non-
nutrient buffer to which 0.5 or 2.0 ytg tunicamycin/ml was
added during the third and fourth hour of development. The
cells were then washed, and shaking was continued. Samples,
taken after 8, 13, and 16 h of development, were diluted and
plated onto the Teflon film of Petriperm dishes for video-
recording. Recording of the 16-h sample of cells treated with
2 ytg tunicamycin/ml was continued until 26 h of develop-
ment. At both concentrations of tunicamycin, aggregation
was inhibited but the cells remained motile. The movement
differed, however, from normal movement. The tunicamy-
cin-treated cells actively extended pseudopods in all direc-
tions, in contrast to normal cells for which polarized
pseudopod formation is typical.
Aggregation-competent cells of D. discoideum are charac-
terized by their ability to form EDTA-stable contacts, in
addition to EDTA-sensitive ones which are already apparent
during the growth phase (Gerisch, 1961). Normally, aggrega-
tion competence is acquired in suspension cultures of D. dis-
coideum strain AX2-214 within 6-8 h after the beginning of
starvation.
The effect of tunicamycin on cell adhesion was investigated
under the same conditions used to study its effect on cell
movement. Samples were taken 8, 16, and 24 h after starva-
tion commenced, and cell adhesion was recorded in an agglu-
tinometer with or without addition of 10 mM EDTA (Figure
1). The EDTA-sensitive contacts were not affected by tunica-
mycin, but the EDTA-stable contacts were inhibited at both
concentrations.
Inhibited expression of the contact site A glycoprotein
Concurrent with the acquisition of EDTA-stable cell adhe-
sion, the 80-kd glycoprotein, called contact site A, accumu-
lates in the plasma membranes of D. discoideum cells. To in-
vestigate whether tunicamycin affects either the synthesis or
expression of this glycoprotein on the cell surface, fluores-
cence was monitored after labeling developing cells with the
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Flg. 1. Cell adhesion in the presence and absence of EDTA. Cells washed
free of nutrient medium were shaken in phosphate buffer. At the time
points indicated, samples were removed from the suspension, the cells
washed and transferred to an agglutinometer (Beug and Gerisch, 1972).
Open symbols: agglutination in the absence of EDTA; closed symbols: in
the presence of 10 mM EDTA. El,E, cells treated with 2.0 yg of
tunicamycin/ml; A,A with 0.5 Ag/ml; 0, 0, untreated control cells.
Tunicamycin was added 2 h, and removed by washing 4 h, after the begin-
ning of starvation (hatched area). Cell agglutination was determined by
recording unscattered light. E is the apparent optical density in the sample,
Eo in an identical sample to which adhesion blocking Fab was added for
complete dissociation of the cells. Thus, E/Eo values close to I indicate
mostly single cells in the experimental sample, low E/Eo values indicate
large aggregates.
monoclonal antibody 12-120-94, which recognizes the contact
site A glycoprotein (Ochiai et al., 1982).
Control cells expressed binding sites for the antibody dur-
ing the first 6 h of development (Figure 2a and b). In com-
parison, the intensity of labeling was reduced within cell
populations treated during the third and fourth hour of
development with 0.1 g of tunicamycin/ml (Figure 2c). Cells
that had been treated with 0.5 itg tunicamycin/ml showed
almost no fluorescence (Figure 2d). After 20 h of develop-
ment the intensity of labeling was about one third of that in
6-h control cells (Figure 2e).
Incomplete form of the contact site A glycoprotein synthe-
sized by tunicamycin-treated cells
Blotting on nitrocellulose of membrane proteins separated
by SDS-polyacrylamide gel electrophoresis has been used to
detect an incomplete form of the glycoprotein synthesized
under the influence of tunicamycin. Starved cells were culti-
vated on Millipore filters. Under these conditions and in the
absence of tunicamycin, they passed through all stages of
development. Experimental groups were transferred together
with the filters onto fiter pads soaked with a solution of 8 sg
tunicamycin/ml and incubated for various periods of time
(Figure 3). Crude membrane preparations of the cells were ex-
tracted with butanol/water for enrichment of the contact site
A glycoprotein in the water phase.
In blots from control cells the 80-kd band of the contact
site A glycoprotein was strongly labeled with monoclonal
antibody 12-120-94. Two minor bands labeled with the same
antibody have been described previously (Ochiai et al., 1982).
One of these bands, designated 140 kd, is seen in Figure 3a.
This band appears during cell development together with the
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Fig. 2. Light scattering (left) and fluorescence (right) of cells labeled with
antibody 12-120-94 and FITC-conjugated anti-mouse-IgG. Cell populations
were analyzed using a FACS IV cell sorter. Cell numbers are plotted on
the ordinate, relative light scattering or fluorescence intensities on the
abscissa. Light scattering is a measure for cell size, which decreases slightly
after starvation. a, cells at the beginning of starvation; b, 6-h control cells;
c, 6-h cells treated with 0.1 g tunicamycin/ml from 2 to 4 h of develop-
ment; d, 6-h cells treated with 0.5 gg tunicamycin/ml from 2 to 4 h of
development; e, 20-h cells treated as in d. Average relative fluorescence in-
tensities (Ire were calculated by subtracting the average fluorescence inten-
sity in panel a (endogenous fluorescence and unspecific antibody binding)
from the average intensities calculated for the other samples. The corrected
value for b was set as 1.
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Fig. 3. Slow expression of a lower mol. wt. form of contact sites A in tuni-
camycin treated cells. Top: labeling of antigens blotted from SDS-poly-
acrylamide gels with antibody 12-120-94. Bottom: times of development
after removal of nutrient medium (columns), and of treatment with 8 Atg
tunicamycin/ml (hatched areas), for the samples shown on top.
80-kd band and might represent a precursor of the contact
site A glycoprotein. Another band, designated 106 kd, ap-
pears during the slug stage; it appe-ars in Figure 3h as a band
labeled faintly. This figure also shows that, in agreement with
previous results, the 80-kd glycoprotein disappears almost
completely after the aggregation stage.
None of the antigens labeled in control cells were seen in
tunicamycin-treated cells. Instead, a new labeled band ap-
peared in the 66 kd position (Figure 3b - g). Figure 3b - e
shows that it is sufficient to incubate the cells with tunicamy-
cin during the third and fourth hours of development in order
to suppress fully the appearance of the complete glycopro-
tein. Synthesis of contact sites A begins after 4 h of develop-
ment. This means that either a precursor glycolipid is synthe-
sized before the commencement of contact site A synthesis,
or tunicamycin is stored within the cells. The latter explana-
tion appears to be correct because incubation of cells with
tunicamycin during the seventh and eighth hours of develop-
ment has an even stronger effect (Figure 3g).
Very little of the 66-kd component was present after 8 h of
development in membranes of tunicamycin-treated cells, i.e.,
at a stage when in control cells the 80-kd glycoprotein was ful-
ly expressed (compare Figure 3a and b). Substantial amounts
of the 66-kd component were not found earlier than 14 h
after starvation (Figure 3e). The delay in the appearance of a
modification of the glycoprotein detectable with antibody
12-120-94 is in agreement with the data obtained by fluores-
cent labeling of living cells (Figure 2).
Under all conditions shown in Figure 3b - g, a discrete
band appeared in the 66 kd position. No material of inter-
mediate mol. wt. between 66 and 80 kd was labeled. This may
be explained in one of two ways: (1) carbohydrate is linked
to the protein in large blocks, so that lack of one block
already shifts the molecule to the 66 kd position; or (2) carbo-
hydrate is linked to the protein in several smaller units, but
in our experiments, the tunicamycin concentration was suf-
ficiently high to fully inhibit N-glycosylation. If (2) were cor-
rect, one would expect material of intermediate size to appear
with decreasing tunicamycin concentration. Therefore, cells
were incubated with either 2.0 or 0.5 jig tunicamycin/ml,
under the same conditions used to determine EDTA-stable
contact formation.
As shown in Figure 4, no intermediate band is seen when
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Fig. 4. Appearance of two discrete bands labeled with [mI]antibody in cells
treated with low concentrations of tunicamycin. a, purified contact site A
glycoprotein as a control; b, water phase from butanol/water extracted
crude membrane fractions of cells treated from 2 to 4 h of development
with 0.5 isg tunicamycin/ml; c, the same, but cells treated with 2.0 iLg of
tunicamycin/ml; d, the butanol- and interphases of the same extract as in
b; e, butanol- and interphases of the same extract as in c. Blots from SDS-
polyacrylamide gels were labeled with antibody 12-120-94.
the 80-kd band of the complete glycoprotein is clearly detect-
able together with the 66-kd band. This result indicates that
carbohydrate is linked in large units to the contact site A
protein.
Two classes of monoclonal antibodies
For purified contact sites A, a carbohydrate content of
33 mg/100 mg protein had been determined (Muiller et al.,
1979). The mol. wt. difference between the complete glyco-
protein and the 66-kd product of tunicamycin-treated cells
seemed to us too small to account for the full carbohydrate
content of the glycoprotein. Therefore, we have screened a
series of eight monoclonal antibodies for their ability to
recognize products of lower mol. wt. that may not be recog-
nized by antibody 12-120-94.
All of these antibodies labeled the 80-kd band of the com-
plete contact site A glycoprotein. With membranes of tuni-
camycin-treated cells, two different labeling patterns were
observed: (1) six antibodies reacted, like 12-120-94, with a
66-kd component; (2) two antibodies reacted with two anti-
gens having apparent mol. wts. of 53 and 66 kd, as shown for
20-6-4 (Figure 5). This antibody faintly labeled a few addi-
tional bands, below the 80-kd glycoprotein, whose positions
were not shifted in tunicamycin-treated cells. The conclusion
is that the 66-kd component synthesized under the influence
of tunicamycin has an antigenic determinant in common with
the complete 80-kd glycoprotein, and that this determinant is
missing in the 53-kd component.
The apparent mol. wts. of 66 and 53 kd were determined
using 100o SDS-polyacrylamide gels. In accord with its high
carbohydrate content the apparent mol. wts. of the complete
contact site A glycoprotein varies with the polyacrylamide
concentration (Muiller et al., 1979). Under the conditions used
here it was 77 kd. Thus, the differences between the apparent
mol. wts. of the three components involved are 11 and 13 kd.
The 80-kd glycoprotein is known to contain phosphoserine
(Coffman et al., 1981; Schmidt and Loomis, 1982). In vivo
incorporation of 3P showed that the 66-kd component syn-
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Fig. 5. Blots from SDS-polyacrylamide gels of plasma membrane-enriched
fractions, labeled with two different monoclonal antibodies and [125l]anti-
mouse lgG. The panels show cells at the beginning of starvation (0 h), con-
trol cells at 8 h after beginning of starvation, cells at 14 h to which 0.5 ytg
tunicamycin/ml was added at 3 h of development (TM). The same mem-
brane preparations were used for labeling with the monoclonal antibodies
mAb 12-120-94 and 20-64. Comparison of the 0 h and 8 h panels shows
the stringent developmental regulation of contact sites A.
thesized in tunicamycin-treated cells is also phosphorylatable
(Figure 6). 32P incorporation into the 53-kd band could not be
detected, possibly because the background was too high.
Distinction of monoclonal antibodies by binding to living
cells
The 80-kd glycoprotein is an integral membrane protein
(Stadler et al., 1982). Part of the molecule is exposed to the
outer membrane surface; it can be labeled in living cells with
antibody 12-120-94 (Figure 2). The six antibodies that failed
to react with the 53-kd component showed the same pattern
of binding to living cells: they labeled the surfaces of aggre-
gation-competent, but not of growth-phase cells. These
results indicate that determinants of the 80-kd glycoprotein
which are present on the 66-kd component, and absent from
the 53-kd component, are exposed to the outer cell surface.
These determinants distinguish contact sites A from other cell
surface antigens which are not developmentally regulated.
No surface labeling of aggregation-competent or growth-
phase cells was observed with antibody 20-6-4. The same
result was obtained with 20-63-1, the other antibody which
labeled the 53-kd component of tunicamycin-treated cells.
These results indicate a determinant within the membranes or
at their inner surface.
Attempts to block cell adhesion by Fab against the glycosyla-
ted contact sites A
Contact sites A neutralize polyspecific Fab that blocks
EDTA-stable cell adhesion (Muller and Gerisch, 1978; Muller
et al., 1979). The polyspecific Fab had been prepared from
rabbit antisera against whole membranes of aggregation com-
petent cells (Beug et al., 1973b) and certainly reacts with more
than one determinant on the contact site A molecule. The
question is whether the carbohydrate moieties of the glyco-
protein are among the target structures to which adhesion
blocking Fab molecules bind.
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Fig. 6. In vivo phosphorylation (left panel), and labeling of membrane pro-
teins with IgG 67/1 from a rabbit that had been immunized with heated,
aggregation competent cells (right panel). [32P]Phosphate was added to cells
3 h after the beginning of starvation. At the same time 0.5 Ag tunicamycin/
ml was added to the experimental samples. Control cells were harvested at
8 h, tunicamycin-treated cells at 14 h after the beginning of starvation
(TM). Plasma membrane enriched fractions were extracted with butanol/
water, the water phase run on SDS-polyacrylamide gels and subjected to
autoradiography. For labeling with rabbit IgG, cells were harvested at the
beginning of starvation (0 h); at 8 h for untreated cells; or at 14 h for cells
to which 0.5 Ag tunicamycin was added at 3 h (TM). Plasma membrane-
enriched fractions were used for SDS-polyacrylamide gel electrophoresis,
blotting and labeling with 67/1 IgG and goat [125I]anti-rabbit IgG.
In earlier experiments, we have immunized rabbits with
heated D. discoideum cells (Beug et al., 1970). Although Fab
from these antisera efficiently bound to the surface of liv-
ing cells, no inhibition of EDTA-stable cell adhesion was
observed (Beug et al., 1973a). IgG from the same rabbit anti-
serum K67/1 used in these earlier studies has now been ap-
plied to label membrane antigens from tunicamycin-treated
and control cells.
In control cells, many bands were labeled (Figure 6). Dif-
fuse background labeling was probably due to glycolipid-
binding antibodies. Particularly the 80-kd band of aggrega-
tion competent cells was strongly labeled. In tunicamycin-
treated cells a band appeared in the same position as the
66-kd band recognized by monoclonal antibodies, whereas
the 53-kd band was not seen. Since the antibodies of rabbit
serum K67/1 recognize carbohydrate structures on glycolipids
and glycoproteins (Beug et al., 1970), it is likely that the 66-kd
but not the 53-kd component of tunicamycin-treated cells
contains carbohydrate.
The fact that K67/1 Fab does not block EDTA-stable cell
adhesion indicates that not all antibodies that bind to the
80-kd glycoprotein also block EDTA-stable cell adhesion,
and that carbohydrate moieties of contact sites A are pro-
bably not the target sites of adhesion blocking Fab.
Fab from antibody 12-120-94, which showed the same
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selectivity for the 66-kd component as the rabbit antibodies,
also did not block EDTA-stable cell adhesion. The mono-
clonal Fab was applied at concentrations up to 1 mg/ml
without a detectable effect. For comparison, 0.1 mg poly-
specific rabbit Fab per ml inhibited under the same conditions
detectably, and 0.6 mg Fab per ml inhibited completely, the
EDTA-stable adhesion.
Discussion
The inhibition by tunicamycin of cell aggregation in D.
discoideum is not due to an overall blockage of cellular func-
tions; this means inhibition of protein synthesis is not the pre-
vailing effect of tunicamycin. Tunicamycin-treated cells re-
main motile for many hours, in contrast to cycloheximide-
treated cells. The defect in co-ordination of pseudopodial ac-
tivity seen in tunicamycin-treated cells resembles the defects
observed in certain mutants (Gerisch, 1980) and suggests the
involvement of a glycoprotein in organized cell movement.
It is tempting to explain the tunicamycin effect on EDTA-
stable cell adhesion by the inhibition of contact site A glyco-
sylation. However, for three reasons our results do not pro-
vide conclusive evidence for a function of the carbohydrate
moiety of this particular glycoprotein in cell adhesion. (1) Fab
fragments from antibodies directed against the glycosylated
protein, and possibly against the carbohydrate moiety itself,
did not block EDTA-stable cell adhesion. (2) Not only the
glycosylation, but also the rate of synthesis or the lifetime of
the protein might be reduced in tunicamycin-treated cells. (3)
The effects of tunicamycin on other glycoproteins have not
been studied.
The appearance of a 53- and 66-kd component in tunica-
mycin-treated cells, and the pattern of their labeling with anti-
bodies, can be explained by assuming a contact site A protein
with an apparent mol. wt. of 53 kd to which two identical or
similar carbohydrate chains, each responsible for an apparent
mol. wt. increase of - 12 kd, are attached by N-glycosyl-
ation. These assumptions are in good agreement with a
carbohydrate content of 33 g/100 g protein (Muller et al..,
1979). This content would correspond to a total mol. wt. of
the carbohydrate of 17.5 kd, and of -9 kd per chain. Our
unpublished data obtained by two-dimensional electrophor-
esis indicate that the carbohydrate does not supply additional
charges to the molecule. Therefore, the 12 kd value for one
carbohydrate chain as indicated by SDS-polyacrylamide gel
electrophoresis is likely to be an overestimate.
Although we think that the assumption of two
N-glycosidically-linked carbohydrate chains is well-
supported, two points need to be considered: (1) part of the
carbohydrate might be linked by 0-glycosidic bonds; and (2)
lack of glycosylation could make the protein highly sensitive
to proteases (Olden et al., 1978, 1982). Thus, it is not exclud-
ed that the 66-kd component is the protein that lacks
N-glycosidically linked carbohydrate, and the 53-kd material
is produced from the 66-kd component by proteolytic
cleavage.
If, nevertheless, the assumption is correct that not only the
80-kd but also the 66-kd component carries a carbohydrate
chain, antibodies like 12-120-94 can be considered as specific
for the N-glycosylated contact sites A. Such antibodies bind
either to the carbohydrate itself, or they recognize a confor-
mation of the protein which is only achieved after glycosyla-
tion, as suggested for an HLA histocompatibility antigen
(Wilson et al., 1981), and for a murine retrovirus antigen
(Pierotti et al., 1981). Because our antibodies react with anti-
gens heated with SDS, it is unlikely to be a specific conforma-
tion of the protein that is recognized.
Previous results have suggested that in D. discoideum more
than one type of carbohydrate is transferred from lipid pre-
cursors to proteins. Rossler et al. (1978) have identified three
different precursor mannolipids. Ivatt et al. (1981) discovered
a group of protein-linked oligosaccharides that remained the
same throughout development up to the completion of cell
aggregation. These oligosaccharides differ by their smaller
sizes from the carbohydrate linked to the contact site A pro-
tein. If antibody 12-120-94 binds directly to this car-
bohydrate, it should be a unique carbohydrate that
distinguishes contact sites A from many other glycoproteins
in D. discoideum membranes, which are not labeled by the
antibody (Ochiai et al., 1982).
Materials and methods
Cells of D. discoideum strain AX2-214 were cultivated axenically at
23 k 1°C and starved in 17 mM Soerensen phosphate buffer pH 6.0 as
described (Malchow et al., 1972). Except for the experiment shown in Figure
3, which was performed with cells spread on Millipore filters (HAWP, 0.45
Am pore size), starved cells were shaken. For in vivo 32P labeling, cells were
washed and resuspended in 10mM imidazole/HCl buffer pH 6.5, and 30 mCi
[32P]phosphate was added to 400 ml of a suspension of 1 x 107 cells/ml. The
measurement of cell adhesion and its inhibition by Fab has been described by
Beug et al. (1973b).
Monoclonal antibodies were collected from hybridomas obtained from
three different BALB/c mice immunized with partially purified contact sites
A, using Al-hydroxide and Bordetella pertussis antigen as adjuvants. The
code numbers of monoclonal antibodies, e.g., 12-120-94, denote the number
of the mouse from which the spleen was obtained, the well from which the
hybridoma was cloned, and the number of the clone picked up from the well.
Cloning, purification of monoclonal antibodies from the culture fluid, their
labeling with 25I, fluorescent labeling of living cells with antibodies and
fluoresceine isothiocyanate (FITC)-conjugated anti-mouse IgG sheep im-
munoglobulins, SDS-polyacrylamide gel electrophoresis, and blotting were
performed as before (Ochiai et al., 1982). Fab was prepared from a monoclo-
nal IgG, antibody by incubating 5 mg IgG for 3 h at37°C with 0.4-0.6 units
of papain, bound to CM-cellulose, in 20 ml phosphate buffered saline con-
taining 2 mM EDTA and 0.1 M mercaptoethanol.
Tunicamycin was fractionated by h.p.l.c. and a fraction corresponding to
peak B of Keenan et al. (1981) was used for all experiments. The purified peak
B tunicamycin was lyophilized, dissolved in ethanol, and kept in a stock solu-
tion of 0.5 mg tunicamycin per ml of 2007o ethanol.
Crude membrane preparations were obtained from frozen cells by ceiitri-
fugation for 20 min at 13 000 g. Either crude or plasma membrane-enriched
fractions were extracted with butanol/water according to Muller et al. (1979).
Plasma membrane-enriched fractions were prepared from crude membrane
preparations using the polyethylene glycol/dextran method of Brunette and
Till (1971), where the plasma membranes are collected from the interphase.
Goat anti-rabbit IgG was a gift from Dr. Heinz Schwarz, Tubingen. Tuni-
camycin was purchased from Calbiochem (La Jolla, CA), FITC-anti-mouse
lgG immunoglobulin from the Institut Pasteur production (Paris), papain
bound to CM-cellulose from E. Merck (Darmstadt, FRG), Petriperm dishes
from Heraeus (Hanau, FRG).
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